While GLP-1 drugs are not yet FDA-approved specifically for alcohol use disorder, prescribers can discuss off-label use in appropriate clinical contexts
However, some clinical practices showed that GLP-1-based therapies have little effect on hepatic steatosis or fibrosis in some patients with T2D and NAFLD 18,19
Looking at the Fine Print Its important to note that these new programs are available without the benefit of any utilization management, said Louis Zollo, a pharmacy practice leader at HR and benefits consulting firm Segal
While great for appetite control, it also means your digestive system is engaged for a longer period
A few commenters emphasized the importance of aligning nutrition measures with clinical workflows and addressing both food insecurity and diet quality
Introduction of Melanotan I Nov 24, 2021 Melanotan IAfamelanotide is a first-in-class, synthetic, 13-amino acid peptide analogue of the endogenous alpha melanocyte-stimulating hormone (-MSH)